Allogene Therapeutics Stock Forecast - 4 Period Moving Average
| ALLO Stock | USD 1.62 0.01 0.61% |
The 4 Period Moving Average forecasted value of Allogene Therapeutics on the next trading day is expected to be 1.64 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.63. Allogene Stock Forecast is based on your current time horizon. Although Allogene Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Allogene Therapeutics' systematic risk associated with finding meaningful patterns of Allogene Therapeutics fundamentals over time.
Allogene |
Allogene Therapeutics 4 Period Moving Average Price Forecast For the 24th of March
Given 90 days horizon, the 4 Period Moving Average forecasted value of Allogene Therapeutics on the next trading day is expected to be 1.64 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.06, and the sum of the absolute errors of 8.63.Please note that although there have been many attempts to predict Allogene Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Allogene Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Allogene Therapeutics Stock Forecast Pattern
| Backtest Allogene Therapeutics | Allogene Therapeutics Price Prediction | Buy or Sell Advice |
Allogene Therapeutics Forecasted Value
In the context of forecasting Allogene Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Allogene Therapeutics' downside and upside margins for the forecasting period are 0.02 and 10.67, respectively. We have considered Allogene Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Allogene Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Allogene Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 107.9755 |
| Bias | Arithmetic mean of the errors | 0.0224 |
| MAD | Mean absolute deviation | 0.1514 |
| MAPE | Mean absolute percentage error | 0.075 |
| SAE | Sum of the absolute errors | 8.6325 |
Predictive Modules for Allogene Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Allogene Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Allogene Therapeutics
For every potential investor in Allogene, whether a beginner or expert, Allogene Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Allogene Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Allogene. Basic forecasting techniques help filter out the noise by identifying Allogene Therapeutics' price trends.View Allogene Therapeutics Related Equities
| Risk & Return | Correlation |
Allogene Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Allogene Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Allogene Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Allogene Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Allogene Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Allogene Therapeutics shares will generate the highest return on investment. By undertsting and applying Allogene Therapeutics stock market strength indicators, traders can identify Allogene Therapeutics entry and exit signals to maximize returns.
Allogene Therapeutics Risk Indicators
The analysis of Allogene Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Allogene Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting allogene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.0 | |||
| Semi Deviation | 5.21 | |||
| Standard Deviation | 8.83 | |||
| Variance | 78.0 | |||
| Downside Variance | 32.01 | |||
| Semi Variance | 27.11 | |||
| Expected Short fall | (6.70) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Allogene Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Allogene Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Allogene Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Allogene Therapeutics Stock: Check out Historical Fundamental Analysis of Allogene Therapeutics to cross-verify your projections. To learn how to invest in Allogene Stock, please use our How to Invest in Allogene Therapeutics guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allogene Therapeutics. If investors know Allogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allogene Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Allogene Therapeutics is measured differently than its book value, which is the value of Allogene that is recorded on the company's balance sheet. Investors also form their own opinion of Allogene Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Allogene Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allogene Therapeutics' market value can be influenced by many factors that don't directly affect Allogene Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allogene Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allogene Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allogene Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.